课题基金 / 基金详情

Mechanism of Hepatitis E Virus Replication and Pathogenesis

Mechanism of Hepatitis E Virus Replication and Pathogenesis
戊型肝炎病毒复制和发病机制
批准号:
8035437
负责人:
XIANG-JIN MENG
金额:
$38.22万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-01 至 2013-06-30

项目摘要

项目成果

XIANG-JIN MENG的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):戊型肝炎病毒(HEV)是人类戊型肝炎的病原体,在发展中国家是一个重要的公共卫生问题,在美国和其他工业化国家也是地方病。与HEV感染相关的死亡率在孕妇中高达28%。由于缺乏细胞培养和实用的动物模型体系,HEV的复制和致病机制尚不清楚,抗戊型肝炎的疫苗仍未问世。我们最近在猪和鸡身上发现的猪和禽流感病毒,以及动物HEV毒株跨物种感染的能力,为HEV的研究开辟了新的途径。戊型肝炎现在是一种公认的人畜共患疾病,猪(可能还有其他动物物种)是已知的宿主。这项建议是基于我们最近发现的猪和禽类HEV,建立猪和鸡的HEV模型,构建人、猪和禽类HEV的感染性cDNA克隆,以及鉴定支持HEV复制的细胞系,这些细胞系是由NIH之前两项关于HEV的奖项(AI01653和AI46505)产生的,这两项奖项现已到期。PI决定不提交竞争性续签,这样他就可以结合到期奖励的方向,并通过提交单一的新提案来扩大他的混合动力汽车研究范围。长期目标是通过以猪、鸡和非人类灵长类动物为模型,通过使用禽-猪、禽-人和猪-人HEV嵌合体来识别在这些过程中具有重要功能的基因组区域,以了解HEV的复制、致病和跨物种感染的机制。在这项建议中,我们的目标是:(1)。确定高变区在戊型肝炎病毒复制和发病机制中的作用(S);了解HEV跨物种感染和宿主易感性的分子基础;以及(3)精细定位HEV衣壳蛋白上的氨基酸残基(S),这对HEV的减毒很重要。这将通过使用包括细胞培养、分子生物学和动物研究在内的标准技术来实现。这些研究将极大地促进我们对HEV复制、致病机制和跨物种感染机制的理解,并将为未来的疫苗开发提供有用的信息。公共卫生相关性:对HEV基础生物学和发病机制知识的缺乏极大地阻碍了HEV疫苗的开发。从这个项目中获得的信息将有助于了解HEV的复制和致病机制,并有助于针对这种重要但极未被研究的人类病原体制定有效的预防和控制策略(如减毒活疫苗)。
英文摘要
DESCRIPTION (provided by applicant): Hepatitis E virus (HEV), the causative agent of human hepatitis E, is an important public health problem in developing countries, and is also endemic in the United States and other industrialized countries. The mortality rate associated with HEV infection is up to 28% in pregnant women. Due to the lack of a cell culture and a practical animal model system, the mechanisms of HEV replication and pathogenesis are poorly understood and a vaccine against hepatitis E is still not available. Our recent discoveries of swine and avian hepatitis E viruses from pigs and chickens and the demonstrated abilities of cross-species infections by the animal HEV strains have opened up new avenues for HEV research. Hepatitis E now is a recognized zoonotic disease, and pigs (and maybe other animal species) are known reservoirs. This proposal is based on our recent discoveries of swine and avian HEVs, establishment of pig and chicken models for HEV, construction of infectious cDNA clones of human, swine and avian HEVs, and identification of cell lines supporting HEV replication resulting from two prior NIH awards on HEV (AI01653, AI46505) which have now expired. The PI decided not to submit competing renewals so that he can combine the directions of the expired awards and expand the scope of his HEV research by submitting a single new proposal. The long-term objectives are to understand the mechanisms of HEV replication, pathogenesis and cross-species infection by using pigs, chickens and non-human primates as models, and by using avian-swine, avian-human and swine-human HEV chimeras to identify genomic regions that are functionally important for these processes. In this proposal, we aim to: (1). Determining the role(s) of the hypervariable region (HVR) in HEV replication and pathogenesis; (2). Understand the molecular basis of HEV cross-species infection and host susceptibility; and (3). Fine-map the amino acid residue(s) on HEV capsid protein that are important for HEV attenuation. This will be accomplished by using standard techniques including cell cultures, molecular biology, and animal studies. The proposed studies will significantly advance our understanding of the mechanisms of HEV replication, pathogenesis and cross- species infection, and will provide useful information for future vaccine development. PUBLIC HEALTH RELEVANCE: The lack of knowledge on HEV basic biology and pathogenesis has greatly hindered the development of a vaccine against HEV. The information gained from this project will help understand the mechanisms of HEV replication and pathogenesis, and help devise effective preventive and control strategies (such as a live-attenuated vaccine) against this important but extremely understudied human pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Animal Model Research for Veterinarians (AMRV)
Animal Model Research for Veterinarians (AMRV)
Animal Model Research for Veterinarians (AMRV)
Animal Model Research for Veterinarians (AMRV)
海外基金